SLC6A13

Protein name: N/D Aliases: GAT2 Substrates: GABA Transport type: N/D Tissue and cellular expression: brain (meninges, ependyma, choroid plexus), retina, liver, kidney, lung Subcellular expression: N/D Disease: epilepsy Locus: 12p13.3 Sequence ID: NP_001177926.1, NM_001190997.2 NP_057699.2, NM_016615.4 Gene ID: 6540 Splice variants: N/D

S6A13_HUMAN (UniProt)

Gene names: SLC6A13, GAT2
Protein names and data: S6A13_HUMAN, Full=Sodium- and chloride-dependent GABA transporter 2;Short=GAT-2, Full=Solute carrier family 6 member 13; Length: 602 a.a., Mass: 68009 Da,
fasta formatted sequence
Function: Terminates the action of GABA by its high affinity sodium-dependent reuptake into presynaptic terminals
Cellular location: Membrane; Multi-pass membrane protein
Tissue specificity: Expressed in brain, kidney, lung, liver and testis

Database cross-references

UniProt: Q9NSD5
NextBio: 25447
Ensembl: ENST00000445055
GeneCard: GC12M000200
PharmGenUCSF: SLC6A13
Guide to Pharmacology: SLC6A13 (930)
GABA transporter subfamily (930)
HGNC: HGNC:11046

Genetic variants

See also Ensembl:ENST00000445055